A marked increase in gastric fluid volume during cardiopulmonary bypass
- PMID: 21765601
- PMCID: PMC3128360
- DOI: 10.3164/jcbn.10-101
A marked increase in gastric fluid volume during cardiopulmonary bypass
Abstract
Major physiological stress occurs during cardiac surgery with cardiopulmonary bypass. This is related to hypothermia and artificial organ perfusion. Thus, serious gastrointestinal complications, particularly upper gastrointestinal bleeding, sometimes follow cardiac surgery. We have compared the antisecretory effects of a preanesthetic H(2) antagonist (roxatidine, cardiopulmonary bypass-H(2) group, n = 15) and a proton pump inhibitor (rabeprazole, cardiopulmonary bypass-PPI group, n = 15) in patients undergoing cardiac surgery with cardiopulmonary bypass, and also compared in patients undergoing a off-pump coronary artery bypass graft surgery (off-pump cardiopulmonary bypass-H(2) group, n = 15). Gastric pH (5.14 ± 0.61) and gastric fluid volume (13.2 ± 2.4 mL) at the end of surgery in off-pump cardiopulmonary bypass-H(2) groups was significantly lower and higher than those in both cardiopulmonary bypass-H(2) (6.25 ± 0.54, 51.3 ± 8.0 mL) and cardiopulmonary bypass-PPI (7.29 ± 0.13, 63.5 ± 14.8 mL) groups, respectively although those variables did not differ between groups after the induction of anesthesia. Plasma gastrin (142 ± 7 pg/mL) at the end of surgery and maximal blood lactate levels (1.50 ± 0.61 mM) in off-pump cardiopulmonary bypass-H(2) group were also significantly lower than those in both cardiopulmonary bypass-H(2) (455 ± 96 pg/mL, 3.97 ± 0.80 mM) and cardiopulmonary bypass-PPI (525 ± 27 pg/mL, 3.15 ± 0.44 mM) groups, respectively. In addition, there was a significant correlation between gastric fluid volume and maximal blood lactate (r = 0.596). In conclusion, cardiopulmonary bypass may cause an increase in gastric fluid volume which neither H(2) antagonist nor PPI suppresses. A significant correlation between gastric fluid volume and maximal blood lactate suggests that gastric fluid volume may predict degree of gastrointestinal tract hypoperfusion.
Keywords: H2 antagonists; cardiopulmonary bypass; gastric acidity; gastrointestinal ischemia; proton pump inhibitors.
Figures


Similar articles
-
The efficacy of preanesthetic proton pump inhibitor treatment for patients on long-term H2 antagonist therapy.Anesth Analg. 2005 Oct;101(4):1038-1041. doi: 10.1213/01.ane.0000166979.99225.a0. Anesth Analg. 2005. PMID: 16192516
-
Efficacy of a single 24-hour pre-anesthetic dose of proton pump inhibitors.J Gastroenterol Hepatol. 2009 Jul;24(7):1244-7. doi: 10.1111/j.1440-1746.2009.05850.x. Epub 2009 Apr 6. J Gastroenterol Hepatol. 2009. PMID: 19486452 Clinical Trial.
-
Adequacy of tissue oxygenation in cardiac surgery: regional measurements.Crit Care Med. 1993 Feb;21(2 Suppl):S77-83. doi: 10.1097/00003246-199302001-00014. Crit Care Med. 1993. PMID: 8428502
-
Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.Health Technol Assess. 2007 Dec;11(51):iii-iv, 1-164. doi: 10.3310/hta11510. Health Technol Assess. 2007. PMID: 18021578 Review.
-
What is the optimum prophylaxis against gastrointestinal haemorrhage for patients undergoing adult cardiac surgery: histamine receptor antagonists, or proton-pump inhibitors?Interact Cardiovasc Thorac Surg. 2013 Mar;16(3):356-60. doi: 10.1093/icvts/ivs483. Epub 2012 Dec 2. Interact Cardiovasc Thorac Surg. 2013. PMID: 23208652 Free PMC article. Review.
Cited by
-
Contribution of nitrergic nerve in canine gingival reactive hyperemia.J Clin Biochem Nutr. 2015 Mar;56(2):98-104. doi: 10.3164/jcbn.14-71. Epub 2015 Mar 1. J Clin Biochem Nutr. 2015. PMID: 25759514 Free PMC article.
References
-
- Geissler HJ, Fischer UM, Grunert S, et al. Incidence and outcome of gastrointestinal complications after cardiopulmonary bypass. Interact Cardiovasc Thorac Surg. 2006;5:239–242. - PubMed
-
- van der Voort PH, Zandstra DF. Pathogenesis, risk factors, and incidence of upper gastrointestinal bleeding after cardiac surgery: is specific prophylaxis in routine bypass procedures needed? J Cardiothorac Vasc Anesth. 2000;14:293–299. - PubMed
-
- Ueki M, Nimura A, Watanabe Y, Maemura T, Konno S. Gastric juice secretion increases during extracorporeal circulation employed in cardiac surgery. Masui. 1994;43:1020–1023. - PubMed
-
- Tanaka S, Nishigaki K, Ojio S, et al. Can negative cardiac effect of proton pump inhibitor and high-dose H2-blocker have clinical influence on patients with stable angina? J Cardiol. 2008;52:39–48. - PubMed
-
- Steinberg KP. Stress-related mucosal disease in the critically ill patient: risk factors and strategies to prevent stress-related bleeding in the intensive care unit. Crit Care Med. 2002;30(Suppl):S362–S364. - PubMed